Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease

Journal of Korean Medical Science

Volumn 20, Issue 4, 2005, Pages 607-611

  Park, Jeong Ah ^a   Shin, Kyung Sue ^b   Youn, Woo Kim ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Coronary Vessels; Kawasaki Disease; Matrix Metalloproteinases; Mucocutaneous Lymph Node Syndrome; Polymorphism, Genetic

Indexed keywords

EID: 24644437876     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.4.607     Document Type: Article

References (27)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observation of 50 cases. Jpn J Allergy 1967; 16: 178-222.
2. Yanagihara R, Todd JK. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 1980; 134: 603-14.
3. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N. Fate of coronary aneu-rysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982; 49: 1758-66.
4. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Inmunopathol 1990; 56: 29-36.
5. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinase and their inhibitors in patients with Kawasaki disease. Circulation 2001; 104: 860-3.
6. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in human stromelysin gene promoter is associated with progression of atherosclerosis. Br Heart J 1995; 73: 209-15.
7. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999; 105: 418-23.
8. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999; 265: 563-8.
9. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788-94.
10. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271: 13055-60.
11. Shimajiri S, Arima N, Tanimoto A, Murata Y, Hamada T, Wang KY, Sasaguri Y. Shortened microsatellite d(CA) 21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett 1999; 455: 70-4.
12. Japanese Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease, 4th ed. Tokyo: Japan Kawasaki Disease Research Committee, 1984.
13. Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985; 56: 846-51.
14. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 2000; 151: 587-9.
15. Kim JS, Park HY, Kwon JH, Im EK, Choi DH, Jang YS, Cho SY. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med J 2002; 43: 473-81.
16. Fujiwara T, Fujiwara H, Hamashima Y. Frequency and size of cownary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardial 1987; 59: 808-11.
17. Delclaux C, Delacourt C, D'ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across the basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-95.
18. Senzaki H, Kobayashi T, Nagasaka H, Nakano H, Kyo S, Yokote Y, Sasaki N. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr Res 2003; 53: 983-8.
19. Cho AR, Hong YM. Matrix metalloproteinase, tissue inhibitors and cytokines in patients with Kawasaki disease. Korean J Pediatr 2004; 47: 656-64.
20. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002; 40: 43-8.
21. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J 2002; 23: 721-5.
22. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biology 2000; 19: 623-9.
23. Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (c-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003; 38: 1363-7.
24. Uehara R, Yashiro M, Hayasaka S, Oki I, Nakamura Y, Muta H, Ishii M, Matsuishi T, Sonobe T, Yanagawa H. Serum alanine aminotransferase concentrations in patients with Kawasaki disease. Pediatr Infect Dis J 2003; 22: 839-42.
25. Wang J, Warzecha D, Wilcken D, Wang XL. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci 2001; 101: 87-92.
26. Nelissen I, Vandenbroeck K, Fiten P, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. J Neuroimmunol 2000; 105: 58-63.
27. Cho HJ, Chae IH, Park KW, Ju JR, Oh S, Lee MM, Park YB. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet 2002; 47: 88-91.